ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of
Open access · bronzeAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2025Guideline
- Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact.Virchows Archiv : an international journal of pathology · 2024Pooled it
- Comparative clinical and molecular profiling of papillary thyroid carcinomas with unilateral and bilateral lateral lymph node metastasis: a retrospective cohort study.Annals of surgical treatment and research · 2026Article
- The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options.Molecular cancer · 2026Review
- Integrative Bioinformatics Analysis Reveals COL13A1 and COL23A1 as Potential Diagnostic and Prognostic Biomarkers in Thyroid Cancer.Health science reports · 2026Article
- Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells.Molecular cancer therapeutics · 2026Article
- Impact of delayed first radioiodine therapy on response evaluation in intermediate risk differentiated thyroid cancer.Scientific reports · 2026Article
- Meta single-cell atlas and xQTL post-GWAS analysis revealed the pathogenic features of thyroid cancer for target therapy: A multi-omics study.Cancer gene therapy · 2026Article
- Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells.European thyroid journal · 2025Review
- MED12 dysregulation: insights into cancer and therapeutic resistance.Naunyn-Schmiedeberg's archives of pharmacology · 2025Review
- Exosome-Mediated Communication in Thyroid Cancer: Implications for Prognosis and Therapeutic Targets.Biochemical genetics · 2025Article
- RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.The Journal of experimental medicine · 2025Article
- Expression pattern, immune signature, and prognostic value of RBM10 in human cancers.Histology and histopathology · 2025Article
- Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation.Endocrine pathology · 2025Article
- Development of animal models to study aggressive thyroid cancers.European thyroid journal · 2025Review
- Review of Surgical Interventions in the Thyroid Gland: Recent Advances and Current Considerations.Methods in molecular biology (Clifton, N.J.) · 2025Review
- RBM10 suppresses malignant transformation in endometrial cancer via the Hippo-YAP signaling pathway.American journal of translational research · 2025Article
- Vitamin C in the Management of Thyroid Cancer: A Highway to New Treatment?Antioxidants (Basel, Switzerland) · 2024Review
- Genomic Landscape and Clinical Features of Advanced Thyroid Carcinoma: A National Database Study in Japan.The Journal of clinical endocrinology and metabolism · 2024Observational
- Molecular impact of mutations in RNA splicing factors in cancer.Molecular cell · 2024Review
22 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 1 institution in 1 country.
Tihana IbrahimpasicHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Bin XuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Iñigo LandaHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Snjezana DoganDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sumit MiddhaDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Venkatraman SeshanDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Shyam DerajeHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Diane L CarlsonDepartment of Pathology, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, New York, New York.
Jocelyn MigliacciDepartment of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Jeffrey A KnaufHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Brian UntchHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Michael F BergerHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Luc MorrisHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
R Michael TuttleDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Timothy ChanHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
James A FaginHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Ronald GhosseinDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. ganlyi@mskcc.org ghosseir@mskcc.org.
Ian GanlyHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. ganlyi@mskcc.org ghosseir@mskcc.org.
Memorial Sloan Kettering Cancer Center · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MSPORE in Thyroid CancerP50CA172012 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI FAGIN, JAMES A · 2014 to 2018
$10.3MMOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTHR01CA050706 · NCI · UNIVERSITY OF CINCINNATI · PI FAGIN, JAMES A · 1995 to 2023
$7.5MONCOGENIC EVENTS IN THYROID NEOPLASIAR01CA072597 · NCI · UNIVERSITY OF CINCINNATI · PI FAGIN, JAMES A · 1997 to 2020
$6.7MFunctionalizing recurrent FAT1 mutations and deletions in oral cancerK08DE024774 · NIDCR · SLOAN-KETTERING INST CAN RESEARCH · PI MORRIS, LUC GORDON TRANG · 2014 to 2018
$682kNCI NIH HHS P30 CA008748NCI NIH HHS P50 CA172012NCI NIH HHS R01 CA050706NCI NIH HHS R01 CA072597NIDCR NIH HHS K08 DE024774
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedCarcinoma, PapillaryFemaleGene Expression Regulation, NeoplasticGenomicsHumansMaleMediator ComplexMiddle AgedMutationNeoplasm ProteinsPromoter Regions, GeneticRNA-Binding ProteinsTelomeraseThyroid Cancer, PapillaryMED12 protein, humanMediator ComplexNeoplasm ProteinsRBM10 protein, humanRNA-Binding ProteinsTelomeraseTERT protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.